Technology Pipeline
OsteoFlux™
OsteoMod™
OsteoFlux-Core™
Is JWP's market-entry product, designed to deliver antibiotics locally within the bone defect site as part of a single-stage surgical approach. By combining natural bone architecture with a proprietary drug-delivery technology, OsteoFlux-Core™ supports infection control while promoting bone regeneration in complex fractures and osteomyelitis. Its localized release strategy is engineered to provide durable antimicrobial activity without compromising the biological integrity of the graft
OsteoFlux-Syn™
Is JWP's flagship product, introducing synchronized multi-antibiotic therapy for the treatment of chronic bone infections in complex fractures. Its smart elution profile enables surgeons to eradicate infection in a single operation while accelerating bone regeneration in healing-compromised environments. By enabling limb salvage in high amputation risk cases, OsteoFlux-Syn™ promises to be a first-in-class solution—and a potential revolution in the treatment of complex bone infections.
OsteoMod-Core™
Coming soon...Coming soon...Coming soon...
OsteoMod-Dent™
Coming soon...Coming soon...Coming soon...
OsteoMod-Onc™
Coming soon...Coming soon...Coming soon...
OsteoFlux-Core™
Is JWP's market-entry product, designed to deliver antibiotics locally within the bone defect site as part of a single-stage surgical approach. By combining natural bone architecture with a proprietary drug-delivery technology, OsteoFlux-Core™ supports infection control while promoting bone regeneration in complex fractures and osteomyelitis. Its localized release strategy is engineered to provide durable antimicrobial activity without compromising the biological integrity of the graft